BIB icon

ProShares Ultra NASDAQ Biotechnology
BIB

Overview Fund Activity

23 hedge funds and large institutions have $4.04M invested in ProShares Ultra NASDAQ Biotechnology in 2025 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 2 increasing their positions, 6 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
23
Holders Change
-1
Holders Change %
-4.17%
% of All Funds
0.31%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
2
Reduced
6
Closed
6
Calls
$332K
Puts
$164K
Net Calls
+$168K
Net Calls Change
+$67K

Top Buyers

1
IMC Chicago
1
IMC Chicago
Illinois
$1.08M
2
Citadel Advisors
2
Citadel Advisors
Florida
$519K
3
Susquehanna International Group
3
Susquehanna International Group
Pennsylvania
$669K
4
PNC Financial Services Group
4
PNC Financial Services Group
Pennsylvania
$48.2K
5
GC
5
Garde Capital
Washington
$11.4K

Top Sellers

1
CCWM
1
Cassaday & Co Wealth Management
Virginia
$0
2
PWM
2
Palumbo Wealth Management
New York
$0
3
TFA
3
Toth Financial Advisory
Virginia
$271K
4
CIA
4
Capital Investment Advisors
Georgia
$336K
5
CWM
5
Crowley Wealth Management
Delaware
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
CWM
26
Crowley Wealth Management
Delaware
– -$50.7K -1,000 Closed
US Bancorp
27
US Bancorp
Minnesota
– -$25.3K -500 Closed
BOJHT
28
Bank of Jackson Hole Trust
Wyoming
– -$7.6K -150 Closed
Simplex Trading
29
Simplex Trading
Illinois
– -$3K -67 Closed
1
2